NCT03081728View on ClinicalTrials.gov

Incidence Of Hemidiaphragmatic Paralysis After Usg Guided Low Dose Interscalene Brachial Plexus Block

NACompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

April 1, 2017

Primary Completion Date

November 16, 2017

Study Completion Date

November 16, 2017

Conditions
Respiratory Insufficiency
Interventions
DEVICE

Interscalene Block with Ropivacaine Hcl 0.2% Inj Vil 10Ml

bolus 10ml of 0.5% ropivacaine followed by infusion @ 2ml/hr of 0.2% ropivacaine

DRUG

IV diclofenac and IV paracetamol

iv diclofenac 75 mg TDS iv paracetamol 1gm TDS

Trial Locations (1)

160012

PGIMER, Chandigarh

All Listed Sponsors
lead

Post Graduate Institute of Medical Education and Research, Chandigarh

OTHER

NCT03081728 - Incidence Of Hemidiaphragmatic Paralysis After Usg Guided Low Dose Interscalene Brachial Plexus Block | Biotech Hunter | Biotech Hunter